Cargando…
COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR
We previously found that the disorder of soluble epoxide hydrolase (sEH)/cyclooxygenase-2 (COX-2)-mediated arachidonic acid (ARA) metabolism contributes to the pathogenesis of the non-alcoholic fatty liver disease (NAFLD) in mice. However, the exact mechanism has not been elucidated. Accumulating ev...
Autores principales: | Zhang, Chen-Yu, Tan, Xiao-Hua, Yang, Hui-Hui, Jin, Ling, Hong, Jie-Ru, Zhou, Yong, Huang, Xiao-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332821/ https://www.ncbi.nlm.nih.gov/pubmed/35897843 http://dx.doi.org/10.3390/ijms23158267 |
Ejemplares similares
-
Effect Of Dual sEH/COX-2 Inhibition on Allergen-Induced Airway Inflammation
por: Dileepan, Mythili, et al.
Publicado: (2019) -
COX-2/sEH Dual Inhibitor PTUPB Alleviates CCl(4)-Induced Liver Fibrosis and Portal Hypertension
por: Zhao, Zhifeng, et al.
Publicado: (2021) -
A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation
por: Yang, Hui-Hui, et al.
Publicado: (2020) -
Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity
por: Jankiewicz, Wojciech K., et al.
Publicado: (2021) -
Association of the sEH gene promoter polymorphisms and haplotypes with preeclampsia
por: Sarı, İsmail, et al.
Publicado: (2020)